英文名稱 |
中文名稱 |
CAS號 |
操作 |
3-Pyridinecarboxylic acid, 2-[4-[(2,3,4-trimethoxyphenyl)methyl]-1-piperazinyl]ethyl ester |
|
2254741-41-6 |
詳細
|
Cyclopropanecarboxamide, N-[5-[4-(cyanomethyl)-2-fluorophenyl]imidazo[1,2-a]pyridin-2-yl]- |
化合物JAK-IN-14 |
1973485-06-1 |
詳細
|
Propanoic acid,2-methyl-2-[4-[[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]carbonyl]amino]methyl]phenoxy]- |
化合物GW590735 |
343321-96-0 |
詳細
|
4-methyl-2-[4-(trifluoromethyl)phenyl]-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]-5-thiazolecarboxamide |
化合物CC618 |
1680204-90-3 |
詳細
|
Unii-2456KW2166 |
化合物 T32308 |
1638266-40-6 |
詳細
|
MLS-573151 |
|
10179-57-4 |
詳細
|
2-[[4-[(2-Methoxybenzoyl)amino]benzoyl]amino]benzoic acid |
2-(4-(2-甲氧基苯甲酰氨基)苯甲酰氨基)苯甲酸 |
693241-54-2 |
詳細
|
PCNA-I1 |
|
444930-42-1 |
詳細
|
CASIN |
|
425399-05-9 |
詳細
|
3-Pyridinecarboxylic acid, 5-bromo- |
5-溴煙酸 |
20826-04-4 |
詳細
|
Teijin Compound 1 HCl |
|
313730-14-1 |
詳細
|
Benzoic acid,4-[[(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino]sulfonyl]- |
|
31816-70-3 |
詳細
|
NG-25 |
N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-(1H-吡咯并[2,3-B]吡啶-4-基氧基)苯甲酰胺 |
1315355-93-1 |
詳細
|
DS18561882 |
|
2227149-22-4 |
詳細
|
AST 487 |
|
630124-46-8 |
詳細
|
Cedirogant |
|
2055496-11-0 |
詳細
|
SR 9238 |
|
1416153-62-2 |
詳細
|
6-Acetyl-8-cyclopentyl-5-methyl-2-[(5-piperidin-4-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one |
|
1637781-04-4 |
詳細
|
BroMosporine |
|
1619994-69-2 |
詳細
|
YKL 06-061 |
|
2172617-15-9 |
詳細
|
NEO2734 |
化合物NEO2734 |
2081072-29-7 |
詳細
|
wu |
化合物PLX51107 |
1627929-55-8 |
詳細
|
(2-(Phenylamino)-1,4-phenylene)bis((4-(pyrrolidin-1-yl)piperidin-1-yl)methanone) |
|
1415800-43-9 |
詳細
|
676500-67-7 |
|
676500-67-7 |
詳細
|
Toceranib |
|
356068-94-5 |
詳細
|
4-[(2-(2-Aminoethoxy)ethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl |
泊馬度胺 4'-PEG1-胺 |
2154342-56-8 |
詳細
|
FIPI |
|
939055-18-2 |
詳細
|
CIVENTICHEM CV-4057 |
拉喹莫德 |
248281-84-7 |
詳細
|
SB 218795 |
化合物 T23316 |
174635-53-1 |
詳細
|
MIBAMPATOR |
|
375345-95-2 |
詳細
|
LMI070 |
化合物LMI 070 |
1562338-42-4 |
詳細
|
tasquinimod |
他喹莫德 |
254964-60-8 |
詳細
|
N-Benzyl-N-hydroxy-2,2-dimethylbutanamide |
|
1956370-21-0 |
詳細
|
BenzenepentanaMide, N-[[3-Methoxy-4-(phenylMethoxy)phenyl]Methyl]-N-[2-(2-pyridinyl)ethyl]- |
化合物 T24437 |
521310-51-0 |
詳細
|
HS1371 |
|
2158197-70-5 |
詳細
|
pf-5274857 |
|
1373615-35-0 |
詳細
|
3-Isoxazolecarboxamide, N-[1-[[2,4-bis(trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-5-(2-furanyl)- |
N-(1-(2,4-雙(三氟甲基)芐基)-1H-吡唑-4-基)-5-(呋喃-2-基)異惡唑-3-甲酰胺 |
2323027-38-7 |
詳細
|
130017-40-2 |
|
130017-40-2 |
詳細
|
NK-252 |
|
1414963-82-8 |
詳細
|
5-(5-((3-Benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)-2-chlorobenzoic acid |
|
432499-63-3 |
詳細
|
N-ETHYL-2-[(6-METHOXYPYRIDIN-3-YL)-(2-METHYLPHENYL)SULFONYLAMINO]-N-(PYRIDIN-3-YLMETHYL)ACETAMIDE |
|
680590-49-2 |
詳細
|
GSK583 |
6-(叔丁基磺?;?-N-(5-氟-1H-吲唑-3-基)喹啉-4-胺 |
1346547-00-9 |
詳細
|
APD668 |
|
832714-46-2 |
詳細
|
ACT 058362; PALOSURAN, |
|
540769-28-6 |
詳細
|
1221277-90-2 |
|
1221277-90-2 |
詳細
|
PFI-1 |
|
1403764-72-6 |
詳細
|
BRD4-IN-1 FL-411 |
2-(4-羥基-3,5-二甲基苯基)-7-甲基-5,6,7,8-四氫吡啶并[4',3':4,5]噻吩并[2,3-D]嘧啶-4(1H)-酮 |
2118944-88-8 |
詳細
|
2-Propenamide, 3-(3-chlorophenyl)-N-[2-[4-(methylsulfonyl)-1-piperazinyl]-2-oxoethyl]-, (2E)- |
|
2505001-54-5 |
詳細
|
N-(2-Methyl-5-((methylamino)methyl)phenyl)-4-((4-phenylquinazolin-2-yl)amino)benzamide |
|
1059734-66-5 |
詳細
|
1H-Pyrazole-4-carboxylic acid, 1-[3-cyano-1-(1-methylethyl)-1H-indol-5-yl]- |
化合物 TIGULIXOSTAT |
1287766-55-5 |
詳細
|
A-443654 |
(ALPHAS)-ALPHA-[[[5-(3-甲基-1H-吲唑-5-基)-3-吡啶基]氧基]甲基]-(S)-1H-吲哚-3-乙胺 |
552325-16-3 |
詳細
|
7-Benzyl-4-(4-(trifluoromethyl)benzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one |
|
1807861-48-8 |
詳細
|
PHT-427 |
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺 |
1191951-57-1 |
詳細
|
ATC 0175 |
|
510733-97-8 |
詳細
|
Glycine, L-g-glutaMyl-S-(phenylMethyl)-L-cysteinyl-2-phenyl-,1,3-diethyl ester, (2R)- |
EZATIOSTAT游離的 |
168682-53-9 |
詳細
|
LDN-193189 2HCL |
|
1435934-00-1 |
詳細
|
Sivelestat |
西維來司他 |
127373-66-4 |
詳細
|
UNC0379 |
|
1620401-82-2 |
詳細
|
[3-[[4-(1,1-Dimethylethoxy)phenoxy]methyl]-3,4-dihydro-2(1H)-isoquinolinyl]-1-naphthalenylmethanone |
3-[[4-(1,1-Dimethylethoxy)phenoxy]methyl]-3,4-dihydro-2(1H)-isoquinolinyl]-1-naphthalenylmethanone |
1380548-02-6 |
詳細
|
FGTI-2734 |
|
1247018-19-4 |
詳細
|
N-((1-(2-(tert-ButylaMino)-2-oxoethyl)piperidin-4-yl)Methyl)-3-chloro-5-fluorobenzaMide |
N-((1-(2-(叔丁基氨基)-2-氧代乙基)哌啶-4-基)甲基)-3-氯-5-氟苯甲酰胺 |
1199236-64-0 |
詳細
|
N-(4,5-Dihydronaphtho[1,2-d]thiazol-2-yl)-2-(3,4-dimethoxyphenyl)acetamide |
|
557782-81-7 |
詳細
|
N-(2-(diMethylaMino)ethyl)-1-(3-((4-((2-Methyl-1H-indol-5-yl)oxy)pyriMidin-2-yl)aMino)phenyl)MethanesulfonaMide |
5-羥基-2-甲基吲哚 |
1308672-74-3 |
詳細
|
LP-935509 |
化合物LP-935509 |
1454555-29-3 |
詳細
|
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- |
達諾司他 |
404951-53-7 |
詳細
|
NVP-BHG712 |
4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-D]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺 |
940310-85-0 |
詳細
|
NVP-BVU 972 |
6-[[6-(1-甲基-1H-吡唑-4-基)咪唑并[1,2-B]噠嗪-3-基]甲基]喹啉 |
1185763-69-2 |
詳細
|
5-Fluoro-2-[[(1S)-1-(4-fluorophenyl)ethyl]amino]-6-[(5-methyl-1H-pyrazol-3-yl)amino]-3-pyridinecarbonitrile |
5-氟-2-[[(1S)-1-(4-氟苯基)乙基]氨基]-6-[(5-甲基-1H-吡唑-3-基)氨基]-3-吡啶腈 |
905586-69-8 |
詳細
|
N1-Benzyl-N1-methyl-N4-(4-methylthiazol-2-yl)piperidine-1,4-dicarboxamide |
|
2194903-42-7 |
詳細
|
KHS101 hydrochloride |
鹽酸KHS101 |
1784282-12-7 |
詳細
|
4H-1-Benzothiopyran-4-one, 2,3-dihydro-2-[1-(phenylMethyl)-4-piperidinyl]- |
化合物Σ1 RECEPTOR ANTAGONIST-1 |
1204401-49-9 |
詳細
|
BCI-121 |
|
432529-82-3 |
詳細
|
3,4-dimethoxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]benzenesulfonamide |
|
199666-03-0 |
詳細
|
Unii-1Z08G7438A |
化合物 DOVRAMILAST |
340019-69-4 |
詳細
|
STF-62247 |
N-(3-甲基苯基)-4-(4-吡啶)-2-噻唑胺 |
315702-99-9 |
詳細
|
GNE-9815 |
化合物GNE-9815 |
2729996-45-4 |
詳細
|
V-9302 |
|
1855871-76-9 |
詳細
|
DY268 |
|
1609564-75-1 |
詳細
|
(E)-3-(3,4-dichlorophenyl)-N-[2-(4-methylsulfonyl-1-piperazinyl)-2-oxoethyl]-2-propenamide |
|
2505001-62-5 |
詳細
|
SBI-797812 |
|
2237268-08-3 |
詳細
|
2-[2-(quinolin-3-yl)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one |
|
724711-21-1 |
詳細
|
BAY 2416964 |
|
2242464-44-2 |
詳細
|
3-((6-((5-chloropyridin-2-yl)amino)pyrimidin-4-yl)amino)-4-(ethylsulfonyl)-N-methylbenzenesulfonamide |
|
1316059-00-3 |
詳細
|
opiranserin hydrochloride |
Opiranserin鹽酸鹽 |
1440796-75-7 |
詳細
|
CC-90010 |
|
1706738-98-8 |
詳細
|
GRP94 |
|
2234897-35-7 |
詳細
|
BAY-218 |
|
2162982-11-6 |
詳細
|
2-(4-bromo-2-thiophenyl)-N-[4-[[6-methyl-2-(1-pyrrolidinyl)-4-pyrimidinyl]amino]phenyl]acetamide |
化合物 CHD1LI 6.11 |
2716890-91-2 |
詳細
|
N-[3-(1,3-benzodioxol-5-yl)-3-(2-methoxyphenyl)propyl]-N-benzylpropanamide |
|
330834-54-3 |
詳細
|
BAY-1797 |
|
2055602-83-8 |
詳細
|
Benzeneacetic acid, 4-[[2-(3-chlorophenyl)-6-(trifluoromethyl)-4-pyridinyl]methyl]- |
|
1606974-33-7 |
詳細
|
1-(4-chlorophenyl)sulfonyl-N-(4-phenyl-2-thiazolyl)-4-piperidinecarboxamide |
|
923418-24-0 |
詳細
|
BAY-179 |
化合物BAY-179 |
|
詳細
|
VY-3-135 |
化合物VY-3-135 |
|
詳細
|
4-(5-(4-Bromophenyl)-3-(3-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide |
|
1222513-26-9 |
詳細
|
Unii-WV3E0S3iqb |
化合物VELUFENACIN |
1648737-78-3 |
詳細
|
SUVN-G3031 |
|
1394808-82-2 |
詳細
|
Benzamide, 3-(cyclopentyloxy)-N-[3-(1-piperidinylcarbonyl)phenyl]- |
化合物GLP-1R MODULATOR L7-028 |
2648317-95-5 |
詳細
|
4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-carboxylic acid [5-chloro-2-(5-oxo-4,5-dihydro-[1,2,4]oxadiazol-3-yl)-phenyl]-amide |
|
1083418-81-8 |
詳細
|
TJ-M2010-5 |
化合物TJ-M2010-5 |
1357471-57-8 |
詳細
|